# Study of SAR97276A in the Treatment of Uncomplicated and Severe Malaria in Adults and Children.

> **NCT00739206** · PHASE2 · TERMINATED · sponsor: **Sanofi** · enrollment: 113 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** SAR97276A

## Key facts

- **NCT ID:** NCT00739206
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-08
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 113 (ACTUAL)
- **Why stopped:** In accordance with protocol's predefined criteria and Data Monitoring Committee recommendation due to insufficient level of efficacy
- **Last updated:** 2010-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00739206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00739206, "Study of SAR97276A in the Treatment of Uncomplicated and Severe Malaria in Adults and Children.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00739206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*